2024
Geographic variation and racial disparities in adoption of newer glucose-lowering drugs with cardiovascular benefits among US Medicare beneficiaries with type 2 diabetes.
PloS one
鈥�Research at a glance
Top areas of exploration
- Diabetes Mellitus, Type 2 , 21 publications
- Obesity , 20 publications
- Hypoglycemic Agents , 12 publications
- Energy Metabolism , 12 publications
Research activity
My publications
Filter publications
87 publications
2024
Glucagon-Like Peptide-1 Receptor Agonists and Risk for Suicidal Ideation and Behaviors in U.S. Older Adults With Type 2 Diabetes : A Target Trial Emulation Study.
Annals of internal medicine
鈥�2024
Glucagon-Like Peptide-1 Receptor Agonists and Risk of Parkinson's Disease in Patients with Type 2 Diabetes: A Population-Based Cohort Study.
Movement disorders : official journal of the Movement Disorder Society
鈥�2024
Heterogeneous treatment effects of metformin on risk of dementia in patients with type 2 diabetes: A longitudinal observational study.
Alzheimer's & dementia : the journal of the Alzheimer's Association
鈥�2024
Heterogeneous treatment effects of sodium-glucose cotransporter 2 inhibitors on risk of dementia in people with type 2 diabetes: A population-based cohort study.
Alzheimer's & dementia : the journal of the Alzheimer's Association
鈥�